Form 4: Neurocrine CSO Gifts Shares, Reduces Direct Stake

Neurocrine Biosciences Chief Scientific Officer Jude Onyia gifted 3,110 shares of common stock, reducing his direct beneficial ownership.

Summary

• Jude Onyia, Chief Scientific Officer of Neurocrine Biosciences Inc. (NBIX), reported a disposition of common stock.
• The transaction involved gifting 3,110 shares of NBIX common stock.
• This gift was effective on February 20, 2026, and no monetary value was received for the shares.
• Following this transaction, Onyia beneficially owns 25,670 shares of Neurocrine Biosciences common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. A gift of shares, while a disposition, does not carry the same implications as a sale for profit and is often related to personal financial planning or philanthropy rather than a change in company outlook.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transaction reports like this Form 4 are routine disclosures required by the SEC. While they provide transparency into executive stock movements, a gift of this size by a Chief Scientific Officer is generally not considered a significant market signal for a company of Neurocrine Biosciences' scale, nor does it directly reflect broader industry trends.

Stakeholder Impact

• Shareholders: Minimal impact as the transaction is a small percentage of the company's total outstanding shares and does not reflect a change in operational performance or strategy.
• Jude Onyia: His direct beneficial ownership of Neurocrine Biosciences common stock decreased by 3,110 shares.

Key Dates

Keywords

Neurocrine Biosciences, NBIX, Insider Transaction, Form 4, Stock Gift, Chief Scientific Officer, Jude Onyia, Equity Ownership